According to sources, Abbott Nutrition announced on Saturday the reopening of their infant formula producing plant in Sturgis, MI. The company closed this past February due to bacterial, and other unsanitary safety issues.
The plant’s closure contributed to the nation’s infant formula supply, prompting the Biden administration to invoke the Defense Production Act with Operation Fly Formula, which was opposed by a majority of Republicans.
Abbott Nutrition said in a statement:
"Abbott is restarting infant formula production at its Sturgis, Mich., facility today after meeting initial requirements agreed to with the Food and Drug administration as part of the consent decree entered into on May 16.
"Abbott is starting production of EleCare and other specialty metabolic formulas, with initial EleCare product release to consumers on or about June 20. We're also working hard to fulfill the steps necessary to restart production of Similac and other formulas and will do so as soon as we can.
"We understand the urgent need for formula and our top priority is getting high-quality, safe formula into the hands of families across America. We will ramp production as quickly as we can while meeting all requirements. We're committed to safety and quality and will do anything to re-earn the trust parents, caregivers and health providers have placed in us for 130 years."
Read the full statement at Abbott.com.
The Week, Abbott.com, AP News.
The Weekly News 